[1]
2021. The effectiveness and safety of subcutaneous immunotherapy for inhalable allergens in patients with respiratory allergies after one year of treatment. Revista Alergia México. 67, 4 (Feb. 2021), 309–315. DOI:https://doi.org/10.29262/ram.v67i4.758.